Brief: Dice Therapeutics Reports Second Quarter 2022 Financial Results And Recent Highlights
Aug 11 (Reuters) - Dice Therapeutics Inc DICE.O :
* DICE THERAPEUTICS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
AND RECENT HIGHLIGHTS
* DICE THERAPEUTICS INC - ECTS ITS CURRENT CASH POSITION TO
FUND
OPERATIONS THROUGH MID-2024 AND EXPECTED KEY CLINICAL MILESTONES
* DICE THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.58
Source text for Eikon: ID:nGNX7Nty1W
Further company coverage: DICE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dice Therapeutics
See all newsBrief: Lilly Completes Acquisition Of Dice Therapeutics
Dice Therapeutics Inc expected to post a loss of 69 cents a share - Earnings Preview
Brief: Eli Lilly Announces Extension Of Tender Offer To Acquire Dice
MoonLake Immunotherapeutics explores sale-sources
MoonLake Immunotherapeutics explores sale-sources